Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Sep 13, 2024 8:50am
403 Views
Post# 36221901

The '' Tip Of The Iceberg''...

The '' Tip Of The Iceberg''...In this video dated Aug, 2024....
.2024-08-12 | Theralase(R) Release's 2Q2024 Financial Statements | TSXV:TLT | Press Release

At the 1.45 time R.Dumoulin said '' Your seeing patients that have an incurable disease''.

At the 3.00 time ...
R.Dumoulin said '' The TLT data set is extremely strong, we are showing world class Duration Of Response, stronger than any other competitors, and these include Major Pharma, and other drugs under consideration under trial''.

In short...
TLT is treating incurable patients(BCG resistant), and has the best CR% in the business, and most of all, TLT CR% is higher than all the Big Pharma treatments out there.

Question...
''Do you have the feeling that what we are seeing right now is just the Tip Of The Iceberg''?


I love Iceberg.



.
<< Previous
Bullboard Posts
Next >>